Christopher Reading's Net Worth
$129 Thousand
Who is Christopher Reading?
Christopher Reading does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOVIE INC., and HOLLIS EDEN PHARMACEUTICALS INC /DE/.
SEC CIK
Christopher Reading's CIK is 0001239658
Past Insider Trading and Trends
2006 was Christopher Reading's most active year for acquiring shares with 2 total transactions. Christopher Reading's most active month to acquire stocks was the month of December. 2007 was Christopher Reading's most active year for disposing of shares, totalling 7 transactions. Christopher Reading's most active month to dispose stocks was the month of January. 2021 saw Christopher Reading paying a total of $0.00 for 124,167 shares, this is the most they've acquired in one year. In 2023 Christopher Reading cashed out on 2,476 shares for a total of $15,153.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOVIE INC. (BIVI) Snapshot price: $2.72
EVP Neuroscience R&DChristopher Reading owns 37,148 units of COMMON STOCK which is worth $101,042.56. In the year 2021 Christopher Reading filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.25% | -2.48K |
$6.12 | -$15,153.12 | 37.15K |
Feb 16
| |||
Form 4
|
∞
| 39.62K |
—
|
—
| 39.62K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HRBR) Snapshot price: $0.916
Chief Scientific OfficerChristopher Reading owns 8,625 units of Common Stock which is worth $7,900.50. In the year 2006 Christopher Reading acquired a total of 3,750 shares in HOLLIS EDEN PHARMACEUTICALS INC /DE/, Christopher also disposed a total of 937 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ equalling to $5,154.36.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| -9.80% | -937.00 |
$5.50 | -$5,154.36 | 8.63K |
Scheduled
|
Feb 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +80.70% | 3.75K |
—
|
—
| 8.4K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||